Larimar Therapeutics (LRMR) Debt Ratio (2014 - 2020)
Larimar Therapeutics (LRMR) posted Debt Ratio of 0.09 for Q1 2020, down 94.37% on a QoQ basis from 1.63 in Q4 2019, and down 25.43% year-over-year from 0.12 in Q2 2019.
Larimar Therapeutics (LRMR) Debt Ratio (2014 - 2020) Analysis & Trends
Larimar Therapeutics' Debt Ratio history runs 7 years deep, the most recent figure standing at 0.09 for Q1 2020.
- Quarterly Debt Ratio fell 25.43% year-over-year to 0.09 in Q1 2020, while the trailing twelve-month figure through Mar 2020 was 0.09 (down 25.43% YoY) and the FY2019 annual result came in at 1.63, up 1204.93% from the prior year.
- Debt Ratio was 0.09 for Q1 2020 at Larimar Therapeutics, down from 1.63 in the prior quarter.
- Across five years, Debt Ratio topped out at 1.63 in Q4 2019 and bottomed at 0.01 in Q3 2016.
- A 5-year average of 0.23 and a median of 0.12 in 2019 frame the typical range for Debt Ratio.
- Annual changes were most pronounced in 2016 — Debt Ratio slumped 58.09% — and 2019, when it jumped 1204.93%.
- Larimar Therapeutics' Debt Ratio stood at 0.01 in 2016, then jumped by 2154.32% to 0.19 in 2017, then sank by 34.21% to 0.12 in 2018, then soared by 1204.93% to 1.63 in 2019, then tumbled by 94.37% to 0.09 in 2020.
- Business Quant data shows LRMR's Debt Ratio at 0.09 in Q1 2020, 1.63 in Q4 2019, and 0.11 in Q3 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | 1.41 |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 0.11 |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 0.05 |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Larimar Therapeutics | 37.00 Mn | -99.85 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | 0.09 |
| Dec 31, 2019 | 1.63 |
| Sep 30, 2019 | 0.11 |
| Jun 30, 2019 | 0.11 |
| Mar 31, 2019 | 0.12 |
| Dec 31, 2018 | 0.12 |
| Sep 30, 2018 | 0.16 |
| Jun 30, 2018 | 0.23 |
| Mar 31, 2018 | 0.22 |
| Dec 31, 2017 | 0.19 |
| Sep 30, 2016 | 0.01 |
| Jun 30, 2016 | 0.01 |
| Mar 31, 2016 | 0.02 |
| Dec 31, 2015 | 0.02 |
| Sep 30, 2015 | 0.02 |
| Jun 30, 2015 | 0.02 |
| Mar 31, 2015 | 0.02 |
| Dec 31, 2014 | 0.05 |
| Sep 30, 2014 | 0.05 |
| Jun 30, 2014 | 0.05 |